Repligen earnings beat by $0.10
Repligen earnings beat by $0.10, revenue topped estimates
Investing.com - Repligen (NASDAQ: RGEN) reported third quarter EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for ...
Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View
Repligen Corporation RGEN reported third-quarter 2024 adjusted earnings per share of 43 cents, which beat the Zacks Consensus Estimate of 34 ...
Repligen Reports Strong Q3 2024 with Revenue Growth
Repligen Corporation reported a robust third quarter of 2024, with a 10% increase in revenue to $155 million year-over-year. The company ...
Repligen's Strong Q3 and Strategic Moves - Markets Insider
In its latest earnings report, Repligen highlighted several key financial metrics, including a significant increase in adjusted net income to ...
Repligen News (RGEN) - Investing.com
Repligen earnings beat by $0.10, revenue topped estimates. Investing.com - Repligen (NASDAQ: RGEN) reported fourth quarter EPS of $0.68, $0.10 better than ...
Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates
Repligen (RGEN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.34 per share.
Repligen Corporation (RGEN) Q3 2024 Earnings Call Transcript
Q3: 2024-11-12 Earnings Summary. Play Call. EPS of $0.43 beats by $0.10 | Revenue of $154.87M (9.69% Y/Y) beats by $1.57M. Repligen Corporation ...
Repligen (RGEN) Earnings Date and Reports 2024 - MarketBeat
Quarterly revenue rose 9.7% year-over-year to $154.87 million, above analysts' expectations of $153.34 million. With a trailing EPS of -$0.04, Repligen's ...
RGEN:NASDAQ - Beat Q4 2022 Earnings by $0.10 - Toggle AI
Repligen reported Q4 2022 Earnings and Beat EPS by $0.10. One week after release the stock has a median return of +9.99%
Repligen Non-GAAP EPS of $0.68 beats by $0.10, revenue of ...
Repligen press release (RGEN): Q4 Non-GAAP EPS of $0.68 beats by $0.10.Revenue of $186.76M (+0.1% Y/Y) beats by $2.35M.YEAR 2023 GUIDANCE:Total reported ...
Repligen Corp. (RGEN) Earnings Reports & Dates | FXEmpire
Dive into Repligen Corp.'s earnings ... $0.58, $0.68, $0.10. +17.24%. Q3 22, Oct 31, 2022 ... A 'beat' occurs when actual earnings surpass analysts' predictions.
Repligen Reports Second Quarter 2024 Financial Results
The company reported in-line with consensus estimates while revenue fell 3.20% compared to the same quarter a year ago. The company said it continues to expect ...
Repligen (RGEN) Down 13.1% Since Last Earnings Report
Repligen reported second-quarter 2024 adjusted earnings per share of 33 cents, which came in line with the Zacks Consensus Estimate. The company ...
Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates
Repligen Corporation RGEN reported first-quarter 2024 adjusted earnings per share of 28 cents, which missed the Zacks Consensus Estimate of ...
Repligen Q3 Earnings Beat Expectations, Highlights Improving ...
Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong ...
Navellier & Associates Inc. Lowers Stake in Repligen Co. (NASDAQ ...
The biotechnology company reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.58 by $0.10. The firm had revenue ...
Repligen (RGEN) Tops Q3 EPS by 10c ; Offers Guidance
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $155 ...
Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates - Zacks
Repligen (RGEN) delivered earnings and revenue surprises of 26.47% and 1.19%, respectively, for the quarter ended September 2024.
Repligen (RGEN) Tops Q3 EPS by 2c, Revenues Beat - StreetInsider
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $49.5 ...
Consolidated Research: 2019 Summary Expectations for Post,
... hit the [ENTER] key). The new research reports ... earnings per share -$0.29 vs $0.10. For the ... Repligen's Recent Financial Performance. For the ...